CCTC Transplant Outcomes Research and Evidence-Based Practice

Question 1

SRTR (Scientific Registry of Transplant Recipients) program-specific reports primarily enable transplant coordinators and programs to do which of the following?

Accepted Answer

Compare their program's risk-adjusted outcomes against national expected outcomes benchmarks

Answer

Access individually identifiable patient records for peer review purposes

Answer

Submit organ offers directly to recipient candidates, bypassing DonorNet

Answer

Track real-time donor hormone management protocols at other centers

Question 2

A transplant center's 1-year kidney graft survival rate is flagged as significantly below the SRTR expected value. Applying a PDCA (Plan-Do-Check-Act) quality improvement cycle, what should happen FIRST?

Accepted Answer

Analyze outcomes data to identify root causes of graft loss before planning any intervention (Plan phase)

Answer

Immediately change the immunosuppression protocol based on a recent journal article

Answer

Report the deficit to the state health department and suspend new listings

Answer

Implement a new patient education program to address non-adherence

Question 3

A study comparing tacrolimus to cyclosporine for prevention of acute rejection reports a p-value of 0.03. What is the correct interpretation of this p-value?

Accepted Answer

There is a 3% probability of observing results this extreme (or more extreme) if there were truly no difference between the drugs

Answer

There is a 3% absolute reduction in rejection risk with tacrolimus

Answer

The study has 97% statistical power to detect this difference

Answer

The result is clinically significant and should immediately change practice

Question 4

When reading a clinical trial on a novel induction immunosuppression agent with a primary endpoint of 'biopsy-proven acute rejection at 12 months,' which is the most important limitation for a transplant coordinator to recognize?

Accepted Answer

The 12-month timeframe may not capture late rejection, chronic allograft nephropathy, or long-term graft survival outcomes

Answer

Biopsy-proven rejection is too subjective to be a scientifically valid endpoint

Answer

Induction agents are only used in kidney transplant and results cannot be generalized

Answer

Acute rejection at 12 months is no longer considered clinically relevant

Question 5

When a transplant program's outcomes are flagged by the SRTR as significantly below expected thresholds for two consecutive reporting periods, which oversight body reviews the program under the UNOS/OPTN membership framework?

Accepted Answer

The UNOS/OPTN Membership and Professional Standards Committee (MPSC)

Answer

The Joint Commission's Transplant Accreditation Committee

Answer

The state department of health transplant licensing board

Answer

The hospital's internal quality assurance department exclusively

Question 6

A transplant center wants to evaluate whether a new electronic reminders intervention reduces immunosuppressant non-adherence. Which study design would provide the highest level of evidence?

Accepted Answer

A randomized controlled trial (RCT) assigning patients to electronic reminders versus usual care

Answer

A retrospective chart review comparing adherence before and after implementing the intervention

Answer

A case series of 20 non-adherent patients who received the intervention

Answer

An expert consensus statement from a transplant society committee